Muriel Liberto, PhD

Muriel Liberto, PhD

Mintz

Contact
View Bio
RSS

Latest Posts › Patent Examinations

Share:

With its Vanda Pharma and Berkheimer memos, USPTO provides increased clarity around personalized medicine patent eligibility

In the time since the Federal Circuit issued its Vanda Pharma decision in April, Vanda Pharm. Inc. v West-Ward Pharm. Intl. Ltd. 887 F.3d 1117 (Fed. Cir. 2018) the US Patent and Trademark Office (USPTO) has issued two memos...more

6/25/2018  /  Evidence , Intellectual Property Protection , Patent Examinations , Patent-Eligible Subject Matter , Patents , Personalized Medicine , Pharmaceutical Patents , Product of Nature Doctrine , USPTO
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide